Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
COCP
#3808
Cocrystal Pharma, Inc. Common Stock
1.0
4
-2.80%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-2.80%
Changement Mensuel
0.00%
Evolution sur 6 mois
-31.58%
Changement Annuel
-40.23%
Clôture Précédente
1.0
7
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
4
Volume
7
Marchés
Actions des Marchés US
Soins de Santé
COCP
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-21.53 M
3.17 M
-2.94 M
-2.15 M
-1.36 M
-3.28 M
Cash from investing activities
0
0
0
0
12 K
12 K
Cash from financing activities
0
0
—
—
0
—
Free cash flow
-21.53 M
3.17 M
-2.94 M
-2.15 M
-1.37 M
-3.29 M
Nouvelles
Cocrystal Pharma начинает клинические испытания препарата от норовируса
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB
Филипп Фрост приобрел акции Cocrystal Pharma на $18 812
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812
Cocrystal Pharma привлекает $1,03 млн через частное размещение
Cocrystal Pharma raises $1.03 million in private placement from directors
Cocrystal Pharma receives $500,000 NIH grant for influenza drug
Cocrystal Pharma закрывает зарегистрированное прямое размещение на $4,7 млн
Cocrystal Pharma closes $4.7 million registered direct offering
Cocrystal Pharma привлекает $4,7 млн через прямое размещение акций
Cocrystal Pharma raises $4.7 million in registered direct offering